- RecruitingPHASE3
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
This study looks at a new two-pill HIV treatment combining doravirine and dolutegravir. It aims to see if switching to this simplified treatment is as good and safe as current three-pill treatments for people living with HIV who have their virus under control.
For: HIV-1-infectionUnited Kingdom - Active not recruitingPHASE3
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
This study looks at two different daily pill combinations for adults newly diagnosed with HIV. It compares a two-drug treatment with a three-drug treatment to see which is safer and works better for controlling the virus.
For: HIV · HIV InfectionsArgentina · Belgium · Denmark - Ongoing, recruitingTherapeutic confirmatory (Phase III)
The Italian Cohort (ITACO) and the Analytical Antiretroviral Treatment Interruption Italian Cohort (ITACO-ATI) study guided by molecular HIV-1 reservoir profiling
This study looks at HIV in people who got it at birth. It's trying to find new ways to understand how the virus hides in the body and if some people can safely stop their HIV medicine under close medical watch.
For: perinatally HIV infectionItaly